Special state aid measures during COVID-19 and corporate dividend policy: Early evidence from Polish public companies
Economics and Business Review · 2022 · 8 (22) (1) · 72-89
DOI: 10.18559/ebr.2022.1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economics and Business Review, 2022. Verfasst von Marta Kluzek und 1 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
The main aim of this paper is to verify whether companies that received special state aid as part of anti-crisis help to mitigate the negative effects of the coronavirus pandemic decided to pay dividends in 2020. The probability of paying dividend was lower for companies that were granted state aid, the variable was statistically significant and the impact was relevant. Among Polish listed companies those ones that received state aid and paid dividends were of average size and age but had the highest level of cash ratio and the lowest level of debt. If a similar crisis occurs in the future the main task for policymakers will be to provide more directed and unambiguous aid for companies in order to avoid unproductive spending as well as to provide general rules that will restrict dividend payment for beneficiaries of any state-aid.
Zitieren
APA
Kluzek, M., & Schmidt-Jessa, K. (2022). Special state aid measures during COVID-19 and corporate dividend policy: Early evidence from Polish public companies. Economics and Business Review, 8 (22)(1), 72-89. https://doi.org/10.18559/ebr.2022.1.5
Vancouver
Kluzek M, Schmidt-Jessa K. Special state aid measures during COVID-19 and corporate dividend policy: Early evidence from Polish public companies. Economics and Business Review. 2022;8 (22)(1):72-89. doi:10.18559/ebr.2022.1.5
BibTeX
@article{Kluzek2022,
author = {Kluzek, Marta and Schmidt-Jessa, Katarzyna},
title = {Special state aid measures during COVID-19 and corporate dividend policy: Early evidence from Polish public companies},
journal = {Economics and Business Review},
year = {2022},
volume = {8 (22)},
number = {1},
pages = {72--89},
doi = {10.18559/ebr.2022.1.5}
}
EUVIMED